Skip to main content

De novo design of artificial haloperoxidase enzymes

NIGMS - National Institute of General Medical Sciences

open
OpenLast verified: 2026-06-20

About This Grant

Project Summary/Abstract Understanding the relationships between three-dimensional protein structure, metal reactivity, and catalytic function promises routes to new drugs and treatments, green chemical processes, and bespoke catalysts. However, the complexity of natural metalloenzymes makes the design of wholly new enzymes one of the greatest challenges in chemical biology. Thus, the de novo design of functional metalloproteins, in which both the protein scaffold and metal-containing active site are designed “from scratch”, presents the most stringent test of our understanding of protein folding and protein-metal structure-function relationships. Using new machine-learning tools for protein design and structure prediction, this work will investigate metalloenzyme structure-function relationships though the de novo design of vanadium- and heme-dependent haloperoxidase enzymes. These enzymes oxidize halides (X–) to X+ using H2O2 to promote halogen incorporation into diverse organic substrates. Halogen atoms often greatly increase the bioactivity of organic compounds, making these reactions important both for human health (e.g., pharmaceuticals, hormones, antibiotics) and the environment (e.g., toxic and ozone-depleting aerosols such as bromoform). The designed proteins will be expressed and characterized using a diverse array of structural, biophysical, and spectroscopic methods. Haloperoxidase activity will be measured, and the effects of primary and secondary sphere mutations will be studied. Potential alternative reactions catalyzed by the enzymes will be assayed, and the binding and activities of similar metal-oxo species (e.g., MoO42–, WO42–) will be investigated. By designing haloperoxidases using only minimal starting motifs, this work will provide valuable insights into the requisite structural and chemical features enabling efficient haloperoxidation catalysis.

Grant Summary

De novo design of artificial haloperoxidase enzymes is a NIGMS - National Institute of General Medical Sciences grant providing up to $75K for university, nonprofit, healthcare org. Applications are due 2028-12-31 (open). Check eligibility and apply with FindGrants.

Not quite the right fit?

Search 9,000+ open grants, or get matches ranked for your organization — free.

Focus Areas

health research

Eligibility

universitynonprofithealthcare org

How to Apply

Funding Range

Up to $75K

Deadline

2028-12-31

Complexity
Medium
  1. 1Confirm your organization is eligible for De novo design of artificial haloperoxidase enzymes from NIGMS - National Institute of General Medical Sciences, checking organization type, location, and any population or project requirements.
  2. 2Gather the required documents and information, including your organization details, project plan, and budget figures.
  3. 3Draft your application narrative and budget addressing the funder's priorities and review criteria. FindGrants can draft each section for you to review and edit.
  4. 4Review every section against the requirements checklist, then export a submission-ready application pack and submit it to NIGMS - National Institute of General Medical Sciences before the deadline.
This record is a past award, contract, or funder profile — useful for research, but not an open grant application. Check the original source for current opportunities from this funder.

Don't want to draft it yourself?

We'll draft the complete application against NIGMS - National Institute of General Medical Sciences's requirements, run a quality review, and email you a submission-ready PDF plus an editable Word doc within 5 business days. Most orders deliver in 24-48 hours. Flat $399, any grant size.

AI Requirement Analysis

Detailed requirements not yet analyzed

Have the NOFO? Paste it below for AI-powered requirement analysis.

0 characters (min 50)

De novo design of artificial haloperoxidase enzymes: Frequently Asked Questions

Who is eligible for the De novo design of artificial haloperoxidase enzymes?

De novo design of artificial haloperoxidase enzymes is offered by NIGMS - National Institute of General Medical Sciences and is generally open to university, nonprofit, healthcare org. It is open to organizations nationwide unless the funder specifies otherwise. Review the specific eligibility terms before applying, since funders set their own requirements around organization type, location, and the population or project being served.

How much funding does the De novo design of artificial haloperoxidase enzymes provide?

De novo design of artificial haloperoxidase enzymes provides up to $75K per award from NIGMS - National Institute of General Medical Sciences. Actual award sizes depend on the scope of your project, available program funds, and the number of applicants, so build a budget that reflects realistic, allowable costs rather than the maximum figure.

When is the De novo design of artificial haloperoxidase enzymes deadline?

Applications for De novo design of artificial haloperoxidase enzymes are due 2028-12-31 (open). Because deadlines can change, verify the date with the funder, NIGMS - National Institute of General Medical Sciences, and give yourself enough time to prepare a complete, competitive application before the close date.

How do you apply for the De novo design of artificial haloperoxidase enzymes?

To apply for De novo design of artificial haloperoxidase enzymes, confirm your eligibility, gather the required documents, and prepare a narrative and budget that address the funder's priorities. FindGrants guides you step by step and can draft each section, then exports a submission-ready application pack for this grant from NIGMS - National Institute of General Medical Sciences.